Grove Bank & Trust’s St Jude Medical STJ Stock Holding History

Grove Bank & Trust’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-70	Closed	-$6K	–	600
2016 Q4	$6K	Buy	+70	New	+$5.56K	﹤0.01%	447

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Grove Bank & Trust's STJ Position: Q1 2017 in Review

Grove Bank & Trust sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 70 shares — an estimated $6K sold.

Grove Bank & Trust first reported a position in STJ in Q4 2016 and held it in 1 quarter. The position peaked at $6K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Grove Bank & Trust reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Grove Bank & Trust sold 70 St Jude Medical shares in Q1 2017, an estimated $6K.
Grove Bank & Trust first reported a position in St Jude Medical in Q4 2016 and held it in 1 quarter.
Grove Bank & Trust's St Jude Medical position peaked at $6K in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Grove Bank & Trust's 13F filing for Q1 2017, filed 28 Apr 2017.